Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
Cardiac arrhythmia, as a common and potentially fatal cardiovascular disease, poses a serious threat to the lives and health of people worldwide. Although various antiarrhythmic drugs have achieved certain therapeutic effects in clinical applications, their side effects and drug resistance still constrain the improvement of treatment efficacy. Natural products have become important resources for the development of antiarrhythmic drugs due to their structural diversity and rich biological activity. Denudatine, as a natural alkaloid isolated from Aconitum spp. and Delphinium spp. plants, has gradually received widespread attention in the fields of pharmacology and medicinal chemistry in recent years due to its regulatory effect on ventricular fiber action potential and inhibitory effect on aconitine induced arrhythmia. This article will provide a systematic review of the chemical structure, plant origin, pharmacological activity, mechanism of action, and pharmacological evaluation of Guangcuique alkaloid, aiming to provide theoretical basis and research direction for the drug development and clinical application of this natural product.
Denudatine, CAS number 26166-37-0, is a natural alkaloid with a complex polycyclic structure, molecular formula C20H27NO4, and molecular weight 343.5110. Its structural core is a typical dihydroisoquinoline skeleton, containing multiple chiral centers that endow it with high stereochemical properties. The LogP value of Guangcuique alkaloid is 2.8560, indicating that it has moderate lipid solubility, which is beneficial for cell membrane permeation and in vivo distribution. Its topological polar surface area (TPSA) is 43.7 Å ², indicating moderate molecular polarity and facilitating binding with biomolecules. Low water solubility (0.1677 mg/mL), but its high lipid solubility and low polarity give it good membrane permeability. It is worth noting that Guangcuique alkaloid exhibits high blood-brain barrier permeability, indicating its potential central nervous system activity or risk of side effects. The hERG channel inhibition test was negative, indicating a low risk of cardiac toxicity. The Ames mutagenicity test result was 0.0, indicating no significant genetic toxicity.
Guangcuique alkaloid is mainly found in Aconitum and Delphinium plants, which are widely distributed in temperate and subarctic regions, especially in southwestern China and the Himalayan Mountains where they have abundant resources. Aconitum plants have a long history of being used in traditional Chinese medicine due to their various alkaloids, which have various pharmacological effects such as pain relief, anti-inflammatory, and cardiovascular regulation.
The extraction of Guangcuique alkaloid is usually carried out by solvent extraction combined with column chromatography separation. Firstly, after the dried plant roots or whole plants are crushed, they are refluxed and extracted using ethanol or methanol as solvents. The extracted solution is concentrated and the pH is adjusted using an acid-base method to separate alkaline alkaloids. Subsequently, high-purity Guangcuique alkaloid was further purified by silica gel column chromatography or high-performance liquid chromatography (HPLC). In recent years, the application of ultrasound assisted extraction and supercritical fluid extraction technology has improved extraction efficiency and purity, reduced the use of harmful solvents, and complied with the principles of green chemistry.
The pharmacological activity of Guangcuique alkaloid is mainly concentrated in the cardiovascular system, especially showing significant effects in anti arrhythmic effects. In vitro electrophysiological experiments have shown that matrine can regulate the action potential of ventricular fibers, prolong the duration of action potential, stabilize myocardial cell membrane potential, and reduce the occurrence of abnormal excitation. Its regulatory effect on sodium and potassium channels helps to restore the electrophysiological stability of myocardial cells.
In addition, Guangcuique alkaloid can inhibit the arrhythmia induced by Aconitine, a strong cardiotoxic alkaloid that often causes severe arrhythmia. Guangcuique alkaloid reduces the risk of arrhythmia by antagonizing the action of aconitine, demonstrating potential detoxification and protective effects.
In animal experiments, Guangcuique alkaloid has shown good anti arrhythmic effects, significantly reducing the frequency and severity of arrhythmia attacks. Its safety evaluation shows that there is no significant cardiac toxicity or neurotoxicity within the effective dose range, supporting its potential as a candidate drug for antiarrhythmic treatment.
The anti arrhythmic mechanism of Guangcuique alkaloid involves the regulation of multiple ion channels, with key targets including KCNH2 (hERG), KCNQ1, SCN5A (cardiac sodium channel Nav1.5), CACNA1C (L-type calcium channel), KCNE1, RYR2 (intracellular calcium release channel), and KCNE2.
Potassium channel regulation Guangcuique alkaloid regulates KCNH2 and KCNQ1 channels, affecting the repolarization process of myocardial cells, prolonging the duration of action potentials, and preventing arrhythmia caused by premature repolarization. Especially, it has no inhibitory effect on hERG channels, reducing the risk of drug-induced long QT syndrome.
Sodium channel regulation By regulating the Nav1.5 sodium channel encoded by SCN5A, scopolamine reduces abnormal sodium influx, stabilizes myocardial cell membrane potential, and reduces the occurrence of arrhythmia.
Calcium channel and calcium release regulation Regulating CACNA1C and RYR2 helps maintain intracellular calcium homeostasis and avoid abnormal cardiac cell excitation caused by calcium overload.
Auxiliary subunit function KCNE1 and KCNE2, as auxiliary subunits of potassium channels, participate in regulating the electrophysiological properties of the channels. Guangcui alkaloid may further affect the electrical activity of myocardial cells by regulating these auxiliary subunits.
In summary, Guangcuique alkaloid works synergistically through multiple targets and pathways to stabilize the electrophysiological environment of myocardial cells and exert anti arrhythmic effects.
The pharmacological parameters of Guangcuique alkaloid show that it has good potential for drug development. Moderate molecular weight, LogP value suitable for oral absorption, and low TPSA conducive to cell membrane penetration. Although its water solubility is low, its solubility and bioavailability can be improved through pharmaceutical formulation technology. High blood-brain barrier permeability suggests that it may affect the central nervous system and requires special attention in safety evaluation.
HERG channel inhibition was negative, reducing the potential risk of cardiac toxicity. Ames test showed no mutagenicity, indicating good genetic safety. Preliminary pharmacokinetic studies have shown that scopolamine has a moderate half-life and good distribution characteristics in vivo, and can effectively reach myocardial tissue concentrations.
However, current research on the metabolic pathways, enzymatic conversion, and in vivo clearance mechanisms of Guangcuique alkaloid is still relatively limited. In the future, further systematic pharmacokinetic and toxicological studies are needed to provide comprehensive data support for clinical applications.
Given the significant pharmacological activity and good safety of Guangcuique alkaloid in anti arrhythmic treatment, its future development prospects as a novel anti arrhythmic drug are broad. Its multi-target regulatory mechanism is expected to overcome the shortcomings of traditional drugs that are prone to drug resistance and side effects caused by a single target, and provide a safer and more effective treatment option.
In addition, the inhibitory effect of Guangcuique alkaloid on the arrhythmia caused by aconitine suggests its potential for detoxification and synergistic enhancement in traditional Chinese medicine formulas, and can be used as a key ingredient to improve the safety of traditional aconitine drugs.
Future research should focus on:
-Systematic pharmacokinetic and toxicological evaluation to clarify its in vivo behavior and safety boundaries;
-Preclinical animal models and early clinical trials to validate their efficacy and safety;
-Optimization of formulation process to improve bioavailability and stability;
-Explore its potential applications in other cardiovascular diseases, such as heart failure and ischemic heart disease.
Through interdisciplinary collaborative research, we aim to promote the transformation of Guangcuique alkaloid from a natural product to a clinical drug, meeting the urgent demand for safe and efficient antiarrhythmic drugs in clinical practice.
As a natural alkaloid derived from Aconitum and Quercus plants, Guangcui alkaloid has shown significant potential as a new type of cardiovascular drug due to its unique chemical structure and significant anti arrhythmic activity. The mechanism of multi-target regulation of myocardial electrophysiology provides new ideas for the design of antiarrhythmic drugs. Combining good pharmacological parameters and safety evaluation, Guangcuique alkaloid is expected to play an important role in future drug development and clinical applications. In the future, it is necessary to strengthen in-depth research on its pharmacological mechanism, pharmacokinetics, and clinical efficacy, promote its clinical translation, and benefit the majority of arrhythmia patients.
